“Morphologic Leukemia-Free State After Venetoclax-Based Therapy in Acute Myeloid Leukemia Is Associated With High Relapse Despite Preserved Short-Term Survival”. 2026. Mediterranean Journal of Hematology and Infectious Diseases 18 (1): e2026048. https://doi.org/10.4084/MJHID.2026.048.